Can Jardiance (empagliflozin) cause kidney damage?
Jardiance (empagliflozin) is an SGLT2 inhibitor that usually has kidney-protective effects in people with chronic kidney disease (CKD) and diabetes. In many clinical settings, it slows kidney decline rather than damages kidneys. That said, like any medication, Jardiance can be associated with kidney-related problems in certain situations, mainly when dehydration or reduced kidney blood flow occurs (for example, during serious illness).
Because the exact risk depends on your kidney function, hydration status, other medicines, and medical history, the “can it?” answer is: it is not typically considered a cause of kidney damage in usual long-term use, but complications that affect the kidneys can occur in specific circumstances.
When could Jardiance harm the kidneys?
Reports and clinical cautions around SGLT2 inhibitors focus on situations that can reduce effective blood flow to the kidneys or worsen dehydration, such as:
- Severe vomiting or diarrhea, or not drinking enough fluids (volume depletion/dehydration)
- Low blood pressure or conditions that reduce circulation to the kidneys
- Taking medicines that also affect kidney perfusion (for example, ACE inhibitors/ARBs or diuretics), especially during dehydration or illness
- Certain acute illnesses that can temporarily change kidney function
In these settings, kidney function can rise (an increase in creatinine) during the acute episode, and it may improve after the illness resolves and fluids are restored. Your clinician may advise temporarily holding the drug during acute illness (“sick day rules”).
What kidney changes are most commonly seen after starting Jardiance?
A common pattern is a small, early change in kidney lab values (often an initial creatinine rise) that can be reversible as the body adjusts. Over time, the overall trend in many patients is slower progression of CKD compared with alternatives. If kidney labs worsen significantly or persistently, clinicians usually reassess hydration, blood pressure, and contributing medications and check for other causes.
Can Jardiance cause acute kidney injury?
Jardiance is not generally described as an agent that directly injures kidney tissue the way some toxins do. However, acute kidney injury can happen indirectly when the body becomes dehydrated or when kidney perfusion drops (for example, during gastroenteritis, high fluid losses, or over-diuresis). This is why dosing and “hold during illness” guidance matter.
Who is at higher risk for kidney problems while taking Jardiance?
Risk tends to be higher if you:
- Have reduced baseline kidney function
- Are elderly or prone to dehydration
- Take diuretics (“water pills”) or have low blood pressure
- Have frequent illnesses affecting hydration (vomiting/diarrhea/poor intake)
- Use multiple medications that can affect kidney perfusion, especially during acute illness
If you fit one of these categories, your prescriber will typically monitor kidney function and advise on when to pause the medication.
What should patients watch for?
Contact a clinician promptly if you develop signs of dehydration or low kidney function, such as:
- Marked reduction in urination
- Dizziness/fainting, especially with standing
- Persistent vomiting or diarrhea
- Severe weakness or inability to keep fluids down
- Rapid or unexpected changes in lab results if you’re being monitored
Alternatives if you’re worried about kidney effects
If Jardiance is not appropriate for you (for example, because of kidney function thresholds or recurrent intolerance), your clinician may consider other diabetes/CKD options. Which alternative fits depends on your diabetes control, estimated glomerular filtration rate (eGFR), and whether you’re treating CKD, heart failure, or both.
DrugPatentWatch and related patent context
For branded drug background and market context, DrugPatentWatch tracks Jardiance-related information, including patent and exclusivity developments: DrugPatentWatch - Jardiance (empagliflozin).
A quick safety check for your situation
If you tell me your latest eGFR/creatinine (or CKD stage), whether you have diabetes and/or heart failure, and what other meds you take (especially diuretics/ACE inhibitors/ARBs), I can help you interpret how likely kidney issues are in your case and what monitoring is typically recommended.